St. Jude Medical Appoints David Dvorak to Its Board of Directors
August 05 2015 - 7:30AM
Business Wire
St. Jude Medical, Inc. (NYSE:STJ), a global medical device
company, today announced the appointment of David C. Dvorak —
President and Chief Executive Officer of Zimmer Biomet — to its
Board of Directors, effective August 4, 2015.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20150805005491/en/
St. Jude Medical Appoints David Dvorak to
its Board of Directors (Photo: Business Wire).
Mr. Dvorak has been President and Chief Executive Officer and a
member of the Board of Directors of Zimmer Holdings Inc., a
worldwide leader in musculoskeletal health care, for eight years.
Mr. Dvorak joined Zimmer Holdings Inc. in December 2001 — shortly
following the company’s spin-off from Bristol-Myers Squibb — and
has served in many executive roles including Group President of
Global Businesses, Chief Legal Officer, Executive Vice President of
Corporate Services, Chief Counsel and Secretary, Chief Compliance
Officer, and Senior Vice President of Corporate Affairs and General
Counsel. He currently serves as a member of the Board of Directors
of the Advanced Medical Technology Association (AdvaMed), and
previously served as Chairman of the Board of AdvaMed.
“We are very pleased to have David Dvorak join the St. Jude
Medical Board of Directors,” said St. Jude Medical Chairman,
President and Chief Executive Officer Daniel J. Starks. “David is a
distinguished leader in the medical technology industry and will
offer a broad strategic perspective to our business. We look
forward to his future contributions as St. Jude Medical continues
to deliver on its innovation-based growth strategy.”
About St. Jude MedicalSt. Jude Medical is a global
medical device manufacturer dedicated to transforming the treatment
of some of the world’s most expensive epidemic diseases. The
company does this by developing cost-effective medical technologies
that save and improve lives of patients around the world.
Headquartered in St. Paul, Minn., St. Jude Medical has four major
clinical focus areas that include cardiac rhythm management, atrial
fibrillation, cardiovascular and neuromodulation. For more
information, please visit sjm.com or follow us on Twitter
@SJM_Media.
Forward-Looking StatementsThis news release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995 that involve risks and
uncertainties. Such forward-looking statements include the
expectations, plans and prospects for the Company, including
potential clinical successes, anticipated regulatory approvals and
future product launches, and projected revenues, margins, earnings
and market shares. The statements made by the Company are based
upon management’s current expectations and are subject to certain
risks and uncertainties that could cause actual results to differ
materially from those described in the forward-looking statements.
These risks and uncertainties include market conditions and other
factors beyond the Company’s control and the risk factors and other
cautionary statements described in the Company’s filings with the
SEC, including those described in the Risk Factors and Cautionary
Statements sections of the Company’s Annual Report on Form 10-K for
the fiscal year ended January 3, 2015 and Quarterly Report on Form
10-Q for the fiscal quarter ended July 4, 2015. The Company does
not intend to update these statements and undertakes no duty to any
person to provide any such update under any circumstance.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150805005491/en/
St. Jude Medical, Inc.Investor Relations:J.C. Weigelt,
651-756-4347jweigelt@sjm.comorMedia Relations:Candace Steele
Flippin, 651-756-3029csflippin@sjm.com
SJM (NYSE:STJ)
Historical Stock Chart
From Apr 2024 to May 2024
SJM (NYSE:STJ)
Historical Stock Chart
From May 2023 to May 2024